The continuous glucose sensor contains a
fluorescent indicator chemistry, which produces a signal that is
proportional to the glucose concentration in the patient's blood.
The reversible nature of the glucose-fluorophore bond enables
monitoring throughout the patient's length of stay with the same
sensor. In clinical testing on
intensive care patients the sensor has continuously monitored
patient's blood glucose for over 100 hours, click
here for detailed report.
The CGM sensor is placed in intensive care patients via a central venous catheter (CVC). As central venous access is required on nearly all ICU patients, the sensor does not require any additional access lines.